Myths vs facts: Homocystein and menopause

Homocysteine is often discussed as a risk marker for cardiovascular disease, especially during menopause. Myth: Homocysteine directly causes hot flashes or mood swings. Fact: Elevated homocysteine is an independent risk factor for vascular damage, but not a direct trigger of menopausal symptoms. The decline in estrogen during menopause can slightly raise homocysteine levels because estrogen promotes homocysteine breakdown. Studies show that hormone replacement therapy (HRT) can lower homocysteine, but the benefit for heart health remains debated. Importantly, homocysteine should be interpreted alongside vitamin B12, B6, and folate status – deficiencies can raise levels. Supplementing these vitamins lowers homocysteine, but evidence for reducing cardiovascular events is weak. For menopausal women, lifestyle changes (diet, exercise, not smoking) are more effective than isolated homocysteine lowering. The predictive value of genetic tests for homocysteine metabolism (e.g., MTHFR) is limited because environmental factors dominate. Bottom line: Homocysteine is a marker, not a symptom – menopause influences it, but clinical relevance is moderate.